Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
The use of DDAVP in children with bleeding disorders
Tal Ben-Ami
,
Shoshana Revel-Vilk
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The use of DDAVP in children with bleeding disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Arginine
100%
Arginine Vasopressin
100%
Bleeding Disorders
100%
Human Plasma
20%
Bleeding Tendency
20%
Safety Profile
20%
Hemophilia
20%
Genetic mutation
20%
Number of children
20%
Desmopressin (DDAVP)
20%
Bleeding Episodes
20%
Plasma-derived Products
20%
Challenge Test
20%
Good Safety
20%
Von Willebrand Disease
20%
Factor Levels
20%
Baseline Factors
20%
Platelet Function Defect
20%
Medicine and Dentistry
Argipressin
100%
Bleeding Disorder
100%
Bleeding Diathesis
20%
Provocation Test
20%
Gene Mutation
20%
Desmopressin
20%
Von Willebrand Disease
20%
Haemophilia A
20%
Cost Efficiency
20%
Thrombocyte Function
20%
Pharmacology, Toxicology and Pharmaceutical Science
Argipressin
100%
Bleeding Disorder
100%
Provocation Test
20%
Bleeding Tendency
20%
Desmopressin
20%
Haemophilia A
20%
Von Willebrand Disease
20%